| __timestamp | Bristol-Myers Squibb Company | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3932000000 | 54823000000 |
| Thursday, January 1, 2015 | 3909000000 | 76691000000 |
| Friday, January 1, 2016 | 4946000000 | 87477000000 |
| Sunday, January 1, 2017 | 6066000000 | 89052000000 |
| Monday, January 1, 2018 | 6547000000 | 100745000000 |
| Tuesday, January 1, 2019 | 8078000000 | 91915000000 |
| Wednesday, January 1, 2020 | 11773000000 | 95905000000 |
| Friday, January 1, 2021 | 9940000000 | 104442000000 |
| Saturday, January 1, 2022 | 10137000000 | 104437000000 |
| Sunday, January 1, 2023 | 10693000000 | 112009000000 |
| Monday, January 1, 2024 | 11949000000 | 121134000000 |
Infusing magic into the data realm
In the ever-evolving landscape of the pharmaceutical and retail sectors, understanding cost efficiency is paramount. Bristol-Myers Squibb Company and Walgreens Boots Alliance, Inc. offer a fascinating study in contrasts. From 2014 to 2023, Walgreens consistently reported a cost of revenue that was approximately 10 times higher than Bristol-Myers Squibb. This disparity highlights the scale and operational differences between a pharmaceutical giant and a retail behemoth.
Bristol-Myers Squibb's cost of revenue grew by about 172% over the decade, peaking in 2020, while Walgreens saw a steadier increase of around 104%, reaching its zenith in 2023. The data for 2024 is incomplete, but the trend suggests Walgreens' continued dominance in revenue expenditure. This comparison underscores the diverse strategies and market dynamics at play in these two sectors, offering valuable insights for investors and industry analysts alike.
Comparing Cost of Revenue Efficiency: Amgen Inc. vs Bristol-Myers Squibb Company
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Incyte Corporation
Who Generates More Revenue? Bristol-Myers Squibb Company or Walgreens Boots Alliance, Inc.
Cost of Revenue: Key Insights for Bristol-Myers Squibb Company and Pharming Group N.V.
Cost Insights: Breaking Down Bristol-Myers Squibb Company and Celldex Therapeutics, Inc.'s Expenses
Cost of Revenue: Key Insights for Walgreens Boots Alliance, Inc. and Cytokinetics, Incorporated
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Vericel Corporation's Expenses
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Supernus Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Wave Life Sciences Ltd.
Cost of Revenue Comparison: Walgreens Boots Alliance, Inc. vs Taro Pharmaceutical Industries Ltd.
Cost of Revenue: Key Insights for Walgreens Boots Alliance, Inc. and Travere Therapeutics, Inc.